• LAST PRICE
    0.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0000
  • Day Range
    ---
  • 52 Week Range
    Low 0.0000
    High 0.0000
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCGNH
CardioGenics Holdings Inc
100.0
0.0x
---
United StatesPDMI
Paradigm Medical Industries Inc
3.3K
0.0x
---
United StatesNMRD
Nemaura Medical Inc
40.0
0.0x
---
United StatesDMSI
Coded Growth Innovation Center Inc
60.0
---
---
United StatesSGLN
SurgLine International Inc
5.7K
---
---
United StatesHSHL
Home Solutions Health Inc
250.0
0.0x
---
As of 2024-11-26

Company Information

CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Contact Information

Headquarters
6865 SW 18th St Ste B13BOCA RATON, FL, United States 33433-7057
Phone
905-673-8501
Fax
---

Executives

Director/Acting Chairman
J. Tabatznik
Director & Chief Executive Officer
Yahia Gawad
Chief Financial Officer
James Essex
Corporate Secretary, Director
Linda Sterling
Independent Director
Karim Murabet

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$100.00
Revenue (TTM)
$0.00
Shares Outstanding
96.1M
CardioGenics Holdings Inc does not pay a dividend.
Beta
1.44
EPS
$-0.01
Book Value
$-0.01
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.